WYKEISHA HIGHSMITH: Open Payments
NPI 1386791051 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 42 payments from 20 companies in 2025. Trend: 2023 $220 · 2024 $659 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $80 |
| Tris Pharma Inc | 3 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| Alkermes, Inc. | 3 | $58 |
| Corium, LLC | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $39 |
Products named: INGREZZA, REXULTI, Jornay PM, ARISTADA, Azstarys, AUSTEDO XR, Dyanavel XR, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
